Skip to main content
$18.87 -$1.13 (-5.7%)

04:00 PM EDT on 10/15/21

Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Current Price $18.87 Mkt Cap $2.4B
Open $20.24 P/E Ratio 0.00
Prev. Close $18.87 Div. (Yield) $0.00 (0.0%)
Daily Range $18.85 - $20.24 Volume 8,671,411
52-Wk Range $12.72 - $54.78 Avg. Daily Vol. 2,437,784

Caps

How do you think NASDAQ:ARRY will perform against the market?

Add Stock to CAPS Watchlist

All Players

258 Outperform
17 Underperform
 

All-Star Players

38 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARRY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Aiming (< 20)
Submitted August 21, 2015

Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year

zzlangerhans (99.00)
Submitted April 25, 2012

It's rather dangerous to red thumb a beaten down cancer or hepatitis biotech, because each one has a finite possibility of rising from the ashes like a Phoenix (or a Pharmasset or Pharmacyclics). Once the market anoints a developmental drug as the… More

NASDAQ:ARRY VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARRY are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ARRY.

Recs

0
Member Avatar nverdurmen (< 20) Submitted: 10/1/2021 6:04:01 PM : Outperform Start Price: $18.55 NASDAQ:ARRY Score: +0.85

Solar industry

Recs

0
Member Avatar Kentuckyfarmer (56.86) Submitted: 8/12/2021 9:17:45 PM : Outperform Start Price: $16.93 NASDAQ:ARRY Score: +13.69

Finally has things going in the right direction. Had some issues with supply chain in Q1 2021 but seems to have that taken care of and ready to move forward.

Recs

1
Member Avatar Aiming (< 20) Submitted: 8/21/2015 8:49:14 AM : Outperform Start Price: $5.15 NASDAQ:ARRY Score: +152.87

Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year

Leaderboard

Find the members with the highest scoring picks in ARRY.

Score Leader

Haugurafpeningum

Haugurafpeningum (36.14) Score: +1,593.44

The Score Leader is the player with the highest score across all their picks in ARRY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
UncleSachse < 20 10/21/2009 Outperform 1Y $2.09 +821.05% +308.71% +512.34 0 Comment
EvilUnicorn 36.31 11/17/2009 Outperform 5Y $2.21 +773.02% +301.82% +471.20 0 Comment
wes29 52.59 6/10/2011 Outperform 3M $2.40 +702.08% +245.87% +456.21 0 Comment
AlpineFirst < 20 3/23/2010 Outperform 3Y $2.47 +679.35% +281.49% +397.86 0 Comment
boardwalken65 30.46 2/10/2012 Outperform 3M $2.65 +626.42% +232.26% +394.16 0 Comment
jettyjett 65.77 10/10/2014 Outperform 5Y $3.15 +511.11% +131.17% +379.94 0 Comment
taddys 86.85 5/23/2011 Outperform 3Y $2.70 +612.96% +237.67% +375.29 0 Comment
stmbpsak 71.77 10/13/2009 Outperform 3Y $2.47 +679.35% +314.84% +364.52 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. 21popsontop 73.47 1/28/2010 Outperform 3Y $2.51 +666.93% +308.11% +358.82 1 Comment
robbg52999 76.54 10/12/2009 Outperform NS $2.51 +666.93% +313.86% +353.07 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARRY.